目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 INCLUSIONS & EXCLUSIONS
1.3.2 MARKETS COVERED
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.2 RESEARCH METHODOLOGY DESIGN
2.2.1 SECONDARY SOURCES
2.2.1.1 KEY DATA FROM SECONDARY SOURCES
2.2.2 PRIMARY SOURCES
2.2.2.1 KEY DATA FROM PRIMARY SOURCES
2.2.2.2 INSIGHTS FROM PRIMARY EXPERTS
2.3 MARET SIZE ESTIMATION
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 MARKET SHARE ESTIMATION
2.6 ASSUMPTIONS FOR THE STUDY
2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 MEDICAL GASES & EQUIPMENT MARKET: OVERVIEW
4.2 ASIA PACIFIC: MEDICAL GASES & EQUIPMENT MARKET, BY TYPE AND COUNTRY
4.3 MEDICAL GASES & EQUIPMENT MARKET: GEOGRAPHIC MIX
4.4 MEDICAL GASES & EQUIPMENT MARKET: REGIONAL MIX
4.5 MEDICAL GASES & EQUIPMENT MARKET: DEVELOPED VS. DEVELOPING MARKETS

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.2 RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.4 CHALLENGES
5.3 INDUSTRY TRENDS
5.4 VALUE CHAIN ANALYSIS
5.5 TECHNOLOGY ANALYSIS
5.5.1 KEY TECHNOLOGY
5.5.1.1 IOT-BASED MONITORING SYSTEMS
5.5.2 COMPLEMENTARY TECHNOLOGY
5.5.2.1 DIGITAL ALARM SYSTEMS
5.6 PORTER'S FIVE FORCE ANALYSIS
5.7 REGULATORY LANDSCAPE
5.7.1 REGULATORY ANALYSIS
5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATION
5.8 PATENT ANALYSIS
5.9 TRADE ANALYSIS
5.10 PRICING ANALYSIS
5.10.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY MEDICAL GAS AND EQUIPMENT TYPE
5.10.2 AVERAGE SELLING PRICE TREND OF MEDICAL GAS AND EQUIPMENT, BY REGION
5.11 KEY CONFERENCES & EVENTS DURING 2024-2025
5.12 KEY STAKEHOLDERS & BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS & BUYING PROCESS
5.12.2 BUYING CRITERIA
5.13 UNMET NEEDS/END USER EXPECTATIONS IN MEDICAL GASES AND EQUIPMENT MARKET
5.14 ADJACENT MARKET ANALYSIS
5.15 ECOSYSTEM MARKET MAP
5.16 CASE STUDY ANALYSIS
5.17 SUPPLY CHAIN ANALYSIS
5.18 TRENDS/DISRUPTION IMPACTING CUSTOMER’S BUSINESS
5.19 INVESTMENT AND FUNDING SCENARIO
5.20 REIMBURSEMENT SCENARIO
5.21 IMPACT OF AI/GENAI / AI IN MEDICAL GASES AND EQUIPMENT MARKET

6 MEDICAL GASES AND EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION AND MILLION UNITS)
6.1 INTRODUCTION
6.2 MEDICAL GASES
6.2.1 PURE MEDICAL GASES
6.2.2 PURE MEDICAL GASES, BY TYPE
6.2.2.1 OXYGEN
6.2.2.2 CARBON DIOXIDE
6.2.2.3 NITROGEN
6.2.2.4 NITROUS OXIDE
6.2.2.5 MEDICAL AIR
6.2.2.6 OTHERS
6.2.4 MEDICAL GAS MIXTURES
6.2.4.1 BLOOD-GAS MIXTURES
6.2.4.2 LUNG DIFFUSION MIXTURES
6.2.4.3 NITROUS OXIDE-OXYGEN MIXTURES
6.2.4.4 CARBON DIOXIDE-OXYGEN MIXTURES
6.2.4.5 LASER-GAS MIXTURES
6.2.4.6 ANAEROBIC GAS MIXTURES
6.2.4.7 AEROBIC GAS MIXTURES
6.2.4.8 HELIUM-OXYGEN MIXTURES
6.2.4.9 OTHERS
6.3 MEDICAL GAS EQUIPMENT
6.3.1 EQUIPMENT ACCESSORIES
6.3.1.1 VACUUM SYSTEMS
6.3.1.2 MANIFOLDS
6.3.1.3 REGULATORS
6.3.1.4 FLOWMETERS
6.3.1.5 HOSES
6.3.1.6 VALVES WITH INTEGRATED PRESSURE REGULATORS (VIPRS)
6.3.1.7 MONITORING SYSTEMS (ALARMS & MONITORS)
6.4.3.8 MEDICAL AIR COMPRESSORS
6.4.3.9 OTHER EQUIPMENT
6.3.2 GAS DELIVERY SYSTEMS
6.3.3 CRYOGENIC PRODUCTS (FREEZERS)

7 MEDICAL GASES AND EQUIPMENT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
7.1 INTRODUCTION
7.2 THERAPEUTIC APPLICATIONS
7.2.1 RESPIRATORY THERAPIES
7.2.2 CARDIOVASCULAR THERAPIES
7.2.3 ANESTHESIA DELIVERY
7.2.4 CRYOSURGERY
7.2.5 OTHER THERAPEUTIC APPLICATIONS
7.3 PHARMACEUTICAL MANUFACTURING & RESEARCH
7.4 DIAGNOSTIC APPLICATIONS
7.4.1 MEDICAL IMAGING
7.4.2 GENERAL LABORATORY APPLICATIONS
7.5 OTHER APPLICATIONS

8 MEDICAL GASES AND EQUIPMENT MARKET, BY END USER, 2022-2029 (USD MILLION)
8.1 INTRODUCTION
8.2 HOSPITALS & CLINICS
8.3 HOME HEALTHCARE
8.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
8.5 ACADEMIC & RESEARCH INSTITUTIONS
8.6 OTHER END USERS

9 MEDICAL GASES AND EQUIPMENT MARKET, BY REGION, 2022-2029 (USD MILLION)
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
9.2.2 US
9.2.3 CANADA
9.3 EUROPE
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
9.3.3 GERMANY
9.3.4 UK
9.3.5 FRANCE
9.3.6 SPAIN
9.3.7 ITALY
9.3.8 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
9.4.2 JAPAN
9.4.3 CHINA
9.4.4 INDIA
9.4.4 AUSTRALIA
9.4.5 SOUTH KOREA
9.4.6 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
9.5.2 BRAZIL
9.5.3 MEXICO
9.5.4 ARGENTINA
9.5.5 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
9.7 GCC COUNTRIES
9.7.1 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS
10.4 MARKET SHARE ANALYSIS
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
10.5.5.1 COMPANY FOOTPRINT
10.5.5.2 REGION FOOTPRINT
10.5.5.3 TYPE FOOTPRINT
10.5.5.4 APPLICATION FOOTPRINT
10.5.5.5 END USER FOOTPRINT
10.6 COMPANY EVALUATION MATRIX: START-UP/SME, 2023
10.6.1 PROGRESSIVE COMPANIES
10.6.2 RESPONSIVE COMPANIES
10.6.3 DYNAMIC COMPANIES
10.6.4 STARTING BLOCKS
10.6.5 COMPETITIVE BENCHMARKING: START-UP/SME, 2023
10.6.5.1 DETAILED LIST OF KEY START-UP/SME
10.6.5.2 COMPETITIVE BENCHMARKING OF START-UP/SME
10.7 COMPETITIVE SITUATION AND TRENDS
10.7.1 PRODUCT LAUNCHES
10.7.2 DEALS
10.7.3 EXPANSIONS
10.7.4 OTHER DEVELOPMENTS
10.8 MEDICAL GASES AND EQUIPMENT MARKET, BRAND/PRODUCT COMPARATIVE ANALYSIS
10.9 R&D ASSESSMENT OF KEY PLAYERS
10.10 VALUATION AND FINANCIAL METRICS OF KEY PLAYERS IN MEDICAL GAS AND EQUIPMENT MARKET

11 COMPANY PROFILES
11.1 KEY PLAYERS
11.1.1 AIR LIQUIDE
11.1.2 LINDE PLC
11.1.3 TAIYO NIPPON SANSO CORPORATION
11.1.4 AIR PRODUCTS AND CHEMICALS, INC.
11.1.5 ATLAS COPCO AB
11.1.6 GCE GROUP
11.1.7 MESSER SE & CO. KGAA
11.1.8 SOL SPA
11.1.9 ROTAREX
11.1.10 NORCO INC
11.1.11 GENSTAR TECHNOLOGIES
11.1.12 SOUTHERN GAS LIMITED
11.1.13 CALOX INC.
11.1.14 ELLENBARRIE INDUSTRIAL GASES.
11.1.15 STEELMAN GASES PVT. LTD.
11.2 OTHER PLAYERS
11.2.1 BUTLER GAS PRODUCTS COMPANY
11.2.2 SCI ANALYTICAL
11.2.3 AMICO GROUP OF COMPANIES
11.2.4 OXYGEN & ARGON WORKS LTD
11.2.5 AOPL
11.2.6 APEX MEDICAL GAS INC
11.2.7 CHENGDU TAIYU INDUSTRIAL GASES CO., LTD.
11.2.8 CARBIDE AND CHEMICALS.
11.2.9 HOLSTON GASES
11.2.10 MEC MEDICAL LTD.

12 APPENDIX
12.1 INSIGHTS OF INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATION
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS